Monthly Archive: April 2014

Apr 30

A new study conducted at the University of Ottawa Heart Institute (UOHI)

A new study conducted at the University of Ottawa Heart Institute (UOHI), published in Cell Reports, highlights the role of a variant of SPG7 gene that likely influences cardiovascular health. Five years of extensive research have led the researchers to conclude that the gene contributes to the development of heart disease through processes that promote …

Continue reading »

Apr 30

A Cochrane review has found slight evidence that suggests a benefit for stem–cell therapy in patients with ischemic heart disease or congestive heart failure

A Cochrane review has found slight evidence that suggests a benefit for stem–cell therapy in patients with ischemic heart disease or congestive heart failure. Bone–marrow–derived stem cell (BMSC) treatment was associated with reductions in mortality and rehospitalization for heart failure at follow–up for more than 1 year.

Apr 29

A significant percentage of patients who can gain the most from taking statins are least willing to take them

A significant percentage of patients who can gain the most from taking statins are least willing to take them, even when they know it will add years to their lives, reports a recent analysis published online in Circulation. The issue could be resolved with the use of a tool for shared decision making in cardiovascular …

Continue reading »

Apr 29

The European Medicines Agency’s (EMA’s) Coordination Group for Mutual Recognition and Decentralised Procedures (CMDh)

The European Medicines Agency’s (EMA’s) Coordination Group for Mutual Recognition and Decentralised Procedures (CMDh) has recently endorsed the recommendations to restrict the use of domperidone–containing antiemetics owing to increasing concerns about adverse cardiac effects. There is a small increased risk for serious adverse cardiac events with domperidone use, including QTc prolongation, torsade de pointes, serious …

Continue reading »

Apr 28

A research published in Circulation Research has reported that fibroblasts could represent an alternative to heart transplants for patients with heart disease

A research published in Circulation Research has reported that fibroblasts could represent an alternative to heart transplants for patients with heart disease. Using cutting edge technology, the researchers noted that cardiac fibroblasts have specific genes called transcription factors and could thus be considered in replacement therapies.

Apr 28

Among patients enrolled in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Among patients enrolled in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), those with an estimated glomerular filtration rate (eGFR) of 30 to 45 ml/min had 43% increased risk of all cancers compared with those who had an eGFR of at least 90. The findings were presented during a poster session at …

Continue reading »

Apr 27

Giving adrenaline to patients after they suffer a cardiac arrest outside the hospital–setting does not increase their odds of surviving long–term

Giving adrenaline to patients after they suffer a cardiac arrest outside the hospital–setting does not increase their odds of surviving long–term, reports a new research published in the journal Resuscitation.

Apr 27

The American Heart Association (AHA)

The American Heart Association (AHA) has released a scientific statement addressing the diagnosis and treatment of fetal cardiac disease. The statement highlights that diagnosis of cardiac disease in the fetus is mostly made with ultrasound; however, newer techniques are now available. Also, strategies for delivery room care now enable stabilization of high–risk fetuses and contribute …

Continue reading »

Apr 26

A new study has reported that birth weight <2.8 kg and being breastfed for less than 3 months could possibly increase

A new study has reported that birth weight

Apr 26

According to a new study, patients with high cholesterol levels prescribed statins have increased their caloric intake by nearly 10%

According to a new study, patients with high cholesterol levels prescribed statins have increased their caloric intake by nearly 10% and their intake of fat by 14% over the recent 10–year period. On the contrary, no changes in eating habits have been observed among statin nonusers.

Older posts «